David Chaplin
Director/Board Member at Phusis Therapeutics, Inc.
David Chaplin active positions
| Companies | Position | Start | End |
|---|---|---|---|
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment. | Director/Board Member | 30/06/2012 | - |
Fast BioPharma Ltd.
 Fast BioPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Fast BioPharma Ltd. develops therapeutic products for treatment of cancer. The company is headquartered in Watlington, the United Kingdom. | Director/Board Member | 31/12/2016 | - |
Career history of David Chaplin
Former positions of David Chaplin
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Director/Board Member | 22/01/2013 | 21/04/2019 |
| Chief Executive Officer | 14/05/2014 | 11/05/2015 | |
| Chief Tech/Sci/R&D Officer | 12/05/2015 | 21/04/2019 | |
| Independent Dir/Board Member | 31/12/2017 | - | |
| President | 14/05/2014 | 11/05/2015 | |
| ONCOTELIC THERAPEUTICS, INC. | Director/Board Member | 06/03/2011 | 29/08/2011 |
| Chief Tech/Sci/R&D Officer | 30/06/2000 | 29/08/2011 | |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France. | Corporate Officer/Principal | 31/12/1998 | 31/12/1999 |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 31/12/1997 | 31/12/1998 |
| The Cancer Research Campaign | Corporate Officer/Principal | 31/12/1991 | 31/12/1997 |
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | 31/12/1989 | 31/12/1991 |
| Aston Biopharma Ltd. | Director/Board Member | - | - |
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of David Chaplin
| University of Essex | Undergraduate Degree |
| The University of Southampton | Graduate Degree |
| University of London | Doctorate Degree |
Statistics
International
| United Kingdom | 9 |
| United States | 3 |
| France | 3 |
Operational
| Director/Board Member | 6 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France. | Health Technology |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
| The Cancer Research Campaign | Finance |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Smart Matrix Ltd.
 Smart Matrix Ltd. Financial ConglomeratesFinance Smart Matrix Ltd. engages in the research and development of medical solutions. It focuses on commercializing its propriety platform technology Smart Matrix, a medical device that acts as a scaffold to assist wound healing. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Finance |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment. | Health Technology |
| Aston Biopharma Ltd. | Commercial Services |
Fast BioPharma Ltd.
Fast BioPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Fast BioPharma Ltd. develops therapeutic products for treatment of cancer. The company is headquartered in Watlington, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- David Chaplin
- Experience